Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin
- 4 June 2003
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 90 (3) , 335-343
- https://doi.org/10.1016/s0168-3659(03)00200-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Polyamidoamine Starburst® dendrimers as solubility enhancersInternational Journal of Pharmaceutics, 2000
- Water-soluble dendritic unimolecular micelles:Journal of Controlled Release, 2000
- Formulation and in Vitro Evaluation of Polymeric Films of Diltiazem Hydrochloride and Indomethacin for Transdermal AdministrationDrug Development and Industrial Pharmacy, 1998
- A Comparative Study of the Transdermal Penetration of a Series of Nonsteroidal Antiinflammatory DrugsJournal of Pharmaceutical Sciences, 1997
- Characteristics of Shed Snake Skin Permeability to Indomethacin and Fatty AlcoholsJournal of Pharmacy and Pharmacology, 1996
- Cardamom oil as a skin permeation enhancer for indomethacin, piroxicam and diclofenacInternational Journal of Pharmaceutics, 1995
- Effect of Various Enhancers on Transdermal Penetration of Indomethacin and Urea, and Relationship between Penetration Parameters and Enhancement FactorsJournal of Pharmaceutical Sciences, 1995
- Encapsulation of Guest Molecules into a Dendritic BoxScience, 1994
- Preparations of Cyclic Sulfoxide Derivatives and Their Evaluation as Transdermal Penetration Enhancers.CHEMICAL & PHARMACEUTICAL BULLETIN, 1992
- Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle.CHEMICAL & PHARMACEUTICAL BULLETIN, 1990